Fertility and Sterility
Volume 74, Issue 5 , Pages 899-908 , November 2000

Risk factors for extrauterine pregnancy in women using an intrauterine device

  • Jean Bouyer, Ph.D.

      Affiliations

    • INSERM U292 (The French Institute of Health and Medical Research) Le Kremlin-Bicêtre, France
    • Corresponding Author InformationReprint requests: J. Bouyer, Ph.D., INSERM U292, Hôpital de Bicêtre, 82 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France (FAX: 33 1 45 21 20 75;
    • ,
  • Emmanuelle Rachou, M.D.

      Affiliations

    • INSERM U292 (The French Institute of Health and Medical Research) Le Kremlin-Bicêtre, France
    • ,
  • Elisabeth Germain (Midwife)

      Affiliations

    • Registre des GEU en Auvergne, Centre Hospitalier Hôtel-Dieu, Service d’Epidémiologie et de Santé Publique, Clermont-Ferrand, France
    • ,
  • Hervé Fernandez, M.D.

      Affiliations

    • INSERM U292 (The French Institute of Health and Medical Research) Le Kremlin-Bicêtre, France
    • Hôpital Antoine Béclère, Service de Gynécologie-Obstétrique, Clamart, France
    • ,
  • Joël Coste, M.D., Ph.D.

      Affiliations

    • INSERM U292 (The French Institute of Health and Medical Research) Le Kremlin-Bicêtre, France
    • ,
  • Jean-Luc Pouly, M.D.

      Affiliations

    • Centre Hospitalier Hôtel-Dieu, Service de Gynécologie-Obstétrique, Clermont-Ferrand, France
    • ,
  • Nadine Job-Spira, M.D.

      Affiliations

    • INSERM U292 (The French Institute of Health and Medical Research) Le Kremlin-Bicêtre, France

Received 7 January 2000 ,Revised 2 May 2000 ,Accepted 2 May 2000.

References 

  1. Chow WH, Daling JR, Cates W, Greenberg RS. Epidemiology of ectopic pregnancy. Epidemiol Rev. 1987;9:70–94
  2. Coste J, Bouyer J, Job-Spira N. Epidémiologie de la grossesse extra-utérine (incidence et facteurs de risque [Epidemiology of ectopic pregnancy: incidence and risk factors]). Contracept Fertil Sex. 1996;24:135–139
  3. Coste J, Job-Spira N, Aublet-Cuvelier B, Germain E, Bouyer J, Fernandez H, et al. Stability of incidence rates of ectopic pregnancy. Results of a population-based register in France. 21ème Congrès de l’Association des Epidémiologistes de Langue Française. Bruxelles, 3–5 Juin 1996. Archives of Public Health 1996;53:32.
  4. Marchbanks P, Annegers J, Coulam C, Strathy J, Kurland L. Risk factors for ectopic pregnancy. A population-based study. JAMA. 1988;259:1823–1827
  5. Coste J, Job-Spira N, Fernandez H, Papiernik E, Spira A. Risk factors for ectopic pregnancy (a case-control study in France, with special focus on infectious factors). Am J Epidemiol. 1991;133:839–849
  6. Job-Spira N, Collet P, Coste J, Bremond A, Laumon B. Facteurs de risque de la grossesse extra-utérine. Résultats d’une enquête cas-témoins dans la région Rhône-Alpes [Risk factors for ectopic pregnancy. Results of a case control study in the Rhone-Alpes region]. Contracept Fertil Sex. 1993;21:307–312
  7. Coste J, Job-Spira N, Fernandez H. Increased risk of ectopic pregnancy with maternal cigarette smoking. Am J Public Health. 1991;81:199–201
  8. Bouyer J, Coste J, Fernandez H, Job-Spira N. Tabac et grossesse extra-utérine. Arguments en faveur d’une relation causale [Smoking and ectopic pregnancy. Arguments for a causal relationship]. Rev Epidemiol Sante Publique. 1998;46:93–99
  9. Coste J, Laumon B, Brémond A, Collet P, Job-Spira N. Sexually transmitted diseases as major causes of ectopic pregnancy (results from a large case-control study in France). Fertil Steril. 1994;62:289–295
  10. Parazzini F, Ferraroni M, Tozzi L, Benzi G, Rossi G, La Vecchia C. Past contraceptive method use and risk of ectopic pregnancy. Contraception. 1995;52:93–98
  11. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy (a meta-analysis of case-control studies). Contraception. 1995;52:23–34
  12. Job-Spira N, Coste J, Aublet-Cuvelier B, Germain E, Fernandez H, Bouyer J, et al.  Fréquence de la grossesse extra-utérine et caractéristiques des femmes traitées. Premiers résultats du registre d’Auvergne [Frequency of ectopic pregnancy and clinical features of treated women. First results of the Auvergne (France) registry]. Presse Méd. 1995;24:351–355
  13. Sandvei R, Ulstein M, Mollen A. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device. Acta Obstet Gynecol Scand. 1987;66:131–135
  14. Aboud E. A five-year review of ectopic pregnancy. Clin Exp Obst Gynecol. 1997;24:127–129
  15. Ory H. Women’s Health Study. Ectopic pregnancy and intrauterine contraceptive devices: new perspectives. Obstet Gynecol. 1981;57:137–144
  16. World Health Organization . Task force on intrauterine devices for fertility regulation. A multi-national case-control study of ectopic pregnancy. Clin Reprod Fertil. 1985;3:131–143
  17. Thorburn J, Bemtsson C, Philipson M, Lindblom B. Background factors of ectopic pregnancy. I. Frequency distribution in case-control study. Eur J Obstet Gynecol Reprod Biol. 1986;23:321–331
  18. Lehfeldt H, Tietze C, Gorstein F. Ovarian pregnancy and the intrauterine device. Am J Obstet Gynecol. 1970;108:1005–1009
  19. Buckler CH. The pathology of intra-uterine contraceptive devices. In:  Berry C editors. Current topics in pathology. Berlin: Springer-Verlag; 1994;p. 307–330
  20. Papiernik E, Rozembaum H, Amblard P, Dephot N, de Mouzon J. Intra-uterine device failure (relation with drug use). Eur J Obstet Gynecol Reprod Biol. 1989;32:205–212
  21. Coste J, Job-Spira N, Aublet-Cuvelier B, Germain E, Glowaczover E, Fernandez H, et al.  Incidence of ectopic pregnancy. First results of a population-based register in France. Human Reprod. 1994;9:742–745
  22. Rothman KJ, Greenland S. Modern epidemiology. Boston: Little, Brown and Co; 1998;
  23. StataCorp. Stata Statistical Software. Release 6. College Station (TX): Stata Corporation, 1999.
  24. Weiss NS, Daling JR, Chow WH. Control definition in case-control studies of ectopic pregnancy. Am J Public Health. 1985;75:67–68
  25. Anteby E, Revel A, Ben-Chetrit A, Rosen B, Tadmor O, Yagel S. Intrauterine device failure (relation to its location within the uterine cavity). Obstet Gynecol. 1993;81:112–114
  26. Blumenfeld Z, Weiner Z, Lorber M, Sujov P, Thaler I. Anticardiolipin antibodies in patients with recurrent pregnancy wastage (treatment and uterine blood flow). Obstet Gynecol. 1991;78:584–589
  27. Balash J, Carmona F, López-Soto A, Font J, Creus M, Fábregues F, et al.  Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Human Reprod. 1993;8:2234–2239
  28. Silver KS, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolopin antibody-positive obstetric patients. Am J Obstet Gynecol. 1993;169:1411–1417
  29. Rubinstein M, Marazzi A, de Fried EP. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization (a prospective, randomized, double-blind placebo-controlled assay). Fertil Steril. 1999;71:825–829
  30. World Health Organization . Task force on intrauterine devices for fertility regulation. Microdose intrauterine levonorgestrel for contraception. Contraception. 1987;35:363–379
  31. Sivin I. Dose and age dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol. 1991;78:291–298
  32. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease (an international perspective). Lancet. 1992;339:785–788
  33. Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Coulson A, et al.  Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine device. IUD Study Group. Lancet. 1998;351:1005–1008
  34. Atrash HK, Friede A, Hogue CJR. Abdominal pregnancy in the United States. Frequency and maternal mortality. Obstet Gynecol. 1987;69:333
  35. Mäkinen JI. Increase of ectopic pregnancies in Finland. Combination of time and cohort effect. Obstet Gynecol. 1989;73:21–24
  36. Neri A, Eckerling B. Influence of smoking and adrenaline (epinephrine) on the utero-tubal insufflation test (Rubin test). Fertil Steril. 1969;20:818–828
  37. Fuentealba B, Nieto M, Croxato HB. Progesterone abbreviates the nuclear retention of estrogen receptor in the rat oviduct and counteracts estrogens action on egg transport. Biol Reprod. 1988;38:63–69
  38. Wollen AL, Flood PR, Sandvei R, Steier JA. Morphological changes in tubal mucosa associated with the use of intra-uterine contraceptive device. Brit J Obstet Gynaecol. 1984;91:1123–1128
  39. Honore LH. A significant association between spontaneous abortion and tubal ectopic pregnancy. Fertil Steril 1979:29–38.
  40. Coulam CB, Johnson PM, Ramsden GH, Wagenknecht DR, Faulk WP, Mc Intyre JA, et al.  Occurrence of ectopic pregnancy among women with recurrent spontaneous abortion. Am J Reprod Immununol. 1989;21:105–107
  41. Fedele L, Acaia B, Parazzini F, Ricciardiello O, Candiani G. Ectopic pregnancy and recurrent spontaneous abortion (two associated reproductive failures). Obstet Gynecol. 1989;73:206–208
  42. Saada M, Job-Spira N, Bouyer J, Coste J, Fernandez H, Germain E, et al.  La récidive de GEU (rôle des antécédents gynéco-obstétricaux, contraceptifs et du tabagisme [Ectopic pregnancy recurrence: role of gynecologic, obstetric, contraceptive and smoking history]). Contracept Fertil Sex. 1997;25:457–462
  43. Coste J, Job-Spira N. Aspects épidémiologiques des grossesses extra-utérines (GEU) [Epidemiology of ectopic pregnancy]. J Gynecol Obstet Biol Repro. 1988;17:991–1001
  44. Bouyer J, Tharaux-Deneux C, Coste J, Job-Spira N. Grossesses extra-utérines (des facteurs liés à l’anomalie de l’oeuf?). [Ectopic pregnancy: risk factors related to egg anomalies?]. Rev Epidemiol et Sante Publique. 1996;44:101–110
  45. Fernandez H, Bouyer J, Coste J, Job-Spira N. The hidden side of ectopic pregnancy (the hormonal factor). Human Reprod. 1996;11:243–244
  46. Sandmire HF. Fertility after intrauterine discontinuation. Adv Contracept. 1986;2:327–335
  47. Chi I. What we have learned from recent IUD studies (a researcher’s perspective). Contraception. 1993;48:81–108
  48. Thorburn J, Philipson M, Linblom B. Fertility after ectopic pregnancy in relation to background factors and surgical treatment. Fertil Steril. 1988;49:595–601
  49. Mäkinen JI, Salmi TA, Nikkanen VPJ, Koskinen EYJ. Encouraging rates of fertility after ectopic pregnancy. Int J Fertil. 1989;34:46–51
  50. Pouly JL, Chapron C, Canis M, Mage G, Wattiez A, Manhès H, et al.  Grossesses extra-utérines sur stérilet. Caractéristiques et fertilité ultérieure [Ectopic pregnancies with intrauterine devices. Characteristics and subsequent fertility]. J Gynecol Obstet Biol Repro. 1991;20:1069–1073
  51. Bernoux A, Job-Spira N, Germain E, Coste J, Bouyer J. Fertility outcome after ectopic pregnancy and use of an intrauterine device at the time of the index ectopic pregnancy. Hum Reprod. 2000;15:1173–1177

☆ Supported by the clinical research department of Paris hospitals (Délégation à la Recherche Clinique, Assistance Publique Hôpitaux de Paris) (EMUL 930602), the National Register Committee (Comité National des Registres, INSERM, DGS), and SCHERING SA Company, France.

PII: S0015-0282(00)01605-8

Fertility and Sterility
Volume 74, Issue 5 , Pages 899-908 , November 2000

Article Tools